{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000159","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.853817+00:00","generated_at":"2026-05-29T00:28:27.988090+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"GRI Bio increases at-the-market offering capacity to $322,468 after $3.6M already sold","bullets":["On December 20, 2024, GRI Bio filed a prospectus supplement to increase shares issuable under its ATM agreement with H.C. Wainwright to up to $322,468.","The company had previously sold approximately $3,604,683 of shares under the same Sales Agreement dated May 20, 2024.","An opinion from Mintz, Levin law firm on the legality of the share issuance was attached as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000159","json":"https://secwatch.observer/filing/0001824293-24-000159.json","markdown":"https://secwatch.observer/filing/0001824293-24-000159.md","text":"https://secwatch.observer/filing/0001824293-24-000159.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/0001824293-24-000159-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/val-20241220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-29T00:28:27.988090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}